Monitoring of chimerism on sorted peripheral CD34+cells in patients with acute leukemia receiving allogeneic bone marrow transplant

被引：0
|
作者：
Bonetti, Maria Ida [1 ]
Peruzzi, Benedetta [2 ]
Mannelli, Francesco [1 ]
Lari, Anna [3 ]
Rondelli, Tommaso [2 ]
Bencini, Sara [1 ]
Cutini, Ilaria [1 ]
Caporale, Roberto [2 ]
Gelli, Anna Maria Grazia [2 ]
Torricelli, Francesca [3 ]
Bosi, Alberto [1 ]
机构：
[1] Univ Firenze, AOU Careggi, SOD Ematol, Florence, Italy
[2] AOU Careggi, Settore Citometria Clin, SOD Lab Gen, Florence, Italy
[3] AOU Careggi, SOD Diagnost Genet, Florence, Italy
来源：
BONE MARROW TRANSPLANTATION | 2018年 / 53卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P038
引用
收藏
页码：173 / 174
页数：2
相关论文
共 50 条
  • [21] The level of peripheral blood circulating CD34+cells is higher in acute promyelocytic leukemia patients with adverse prognostic factors
    Zeng, Hui
    Yin, Ling-Di
    Li, Ping
    Yuan, Yan-hui
    Guan, Chao-Yang
    Xie, Ting
    Zhang, Qi-Guo
    HEMATOLOGY, 2016, 21 (09) : 513 - 519
  • [22] Relative distribution of different compartments of CD34+cells in the bone marrow of patients with myelodysplastic syndromes
    Matarraz, S.
    Lopez, A.
    Salvador, C.
    Fernandez-Mosteirin, N.
    Giralt, M.
    Orfao, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 233 - 233
  • [23] Molecular phenotypic changes in bone marrow CD34+cells of patients with polycythemia rubra vera
    Steidl, U
    Kobbe, G
    Er, TS
    Kliszewski, S
    Martin, S
    Fenk, R
    Rohr, UP
    Haas, R
    Kronenwett, R
    JOURNAL OF GENE MEDICINE, 2003, 5 (03): : S24 - S24
  • [24] Sensitive next-generation sequencing based detection of measurable residual disease in sorted CD34+cells of patients with acute myeloid leukemia
    Burkhard-Meier, C.
    Stasik, S.
    Oelschlaegel, U.
    Middeke, M.
    Sockel, K.
    Schetelig, J.
    Stoelzel, F.
    Roellig, C.
    Bornhaeuser, M.
    Platzbecker, U.
    Thiede, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 42 - 43
  • [25] Mixed chimerism of bone marrow CD34+ progenitor cells (genotyping, BCR/ABL analysis) after allogeneic transplantation for chronic myelogenous leukemia
    Thiele, J
    Wickenhauser, C
    Kvasnicka, HM
    Varus, E
    Kleppe, S
    Beelen, DW
    Schaefer, UW
    TRANSPLANTATION, 2002, 74 (07) : 982 - 986
  • [26] Natalizumab increases circulating CD34+cells with an impaired functional potential in patients with multiple sclerosis. Bone marrow derived CD34+cells remain unaffected
    Saure, C.
    Zohren, F.
    Bruns, I
    Schroeder, T.
    Caddedu, R. P.
    Fischer, U.
    Kobbe, G.
    Hartung, H. P.
    Kieseier, B.
    Haas, R.
    ONKOLOGIE, 2010, 33 : 218 - 218
  • [27] Arsenic Primes Human Bone Marrow CD34+Cells for Erythroid Differentiation
    Zhang, Yuanyuan
    Wang, Shasha
    Chen, Chunyan
    Wu, Xiao
    Zhang, Qunye
    Jiang, Fan
    BIOINORGANIC CHEMISTRY AND APPLICATIONS, 2015, 2015
  • [28] Cell cycle status of CD34+cells in human fetal bone marrow
    Koenig, JM
    Luttge, B
    Benson, NA
    Christensen, RD
    EARLY HUMAN DEVELOPMENT, 2001, 65 (02) : 159 - 163
  • [29] Age and stress related phenotypical changes in bone marrow CD34+cells
    Taraldsrud, Eli
    Grgaard, Haakon K.
    Solheim, Svein
    Lunde, Ketil
    Flisand, Yngvar
    Arnesen, Harald
    Seljeflot, Ingebjrg
    Egeland, Torstein
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2009, 69 (01): : 79 - 84
  • [30] Monitoring of chimerism by PCR in patients after allogeneic bone marrow transplantation.
    Caenazzo, L
    Ponzano, E
    Messina, C
    Gazzola, MV
    Destro, R
    Cesaro, S
    Zanesco, L
    Cortivo, P
    BONE MARROW TRANSPLANTATION, 1999, 23 : S49 - S49
12345